Across TCGA pan-cancer cohorts, POM121L14P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated POM121L14P data layer.
The strongest signal is observed in cholangiocarcinoma (CHOL), where higher POM121L14P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated POM121L14P expression acts as an unfavorable survival marker, although some lineages such as LIHC and SKCM show a favorable association.
CHOL, READ, and COAD are the cancer types where POM121L14P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.